Miquel Vila-Perello

Dr. Vila-Perelló is a scientist, entrepreneur, and CEO of SpliceBio, a clinical-stage company developing next-generation gene therapies. He has led the company through significant growth, including one of the largest Series B financings in the gene therapy space (2025), to advance its lead program into clinical development. He earned his Ph.D. from the University of Barcelona, following postdoctoral studies at The Rockefeller University, later joined Princeton University as a Research Scholar.